1. Home
  2. BCAB vs QIPT Comparison

BCAB vs QIPT Comparison

Compare BCAB & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • QIPT
  • Stock Information
  • Founded
  • BCAB 2007
  • QIPT 1993
  • Country
  • BCAB United States
  • QIPT United States
  • Employees
  • BCAB N/A
  • QIPT N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • QIPT
  • Sector
  • BCAB Health Care
  • QIPT
  • Exchange
  • BCAB Nasdaq
  • QIPT Nasdaq
  • Market Cap
  • BCAB 101.0M
  • QIPT 103.8M
  • IPO Year
  • BCAB 2020
  • QIPT N/A
  • Fundamental
  • Price
  • BCAB $1.57
  • QIPT $2.41
  • Analyst Decision
  • BCAB Buy
  • QIPT Strong Buy
  • Analyst Count
  • BCAB 2
  • QIPT 3
  • Target Price
  • BCAB $5.00
  • QIPT $7.67
  • AVG Volume (30 Days)
  • BCAB 1.2M
  • QIPT 144.0K
  • Earning Date
  • BCAB 11-07-2024
  • QIPT 12-16-2024
  • Dividend Yield
  • BCAB N/A
  • QIPT N/A
  • EPS Growth
  • BCAB N/A
  • QIPT N/A
  • EPS
  • BCAB N/A
  • QIPT N/A
  • Revenue
  • BCAB $11,000,000.00
  • QIPT $244,231,000.00
  • Revenue This Year
  • BCAB N/A
  • QIPT $24.53
  • Revenue Next Year
  • BCAB N/A
  • QIPT $3.69
  • P/E Ratio
  • BCAB N/A
  • QIPT N/A
  • Revenue Growth
  • BCAB N/A
  • QIPT 29.31
  • 52 Week Low
  • BCAB $1.14
  • QIPT $2.34
  • 52 Week High
  • BCAB $4.02
  • QIPT $5.29
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 40.91
  • QIPT 33.91
  • Support Level
  • BCAB $1.33
  • QIPT $2.34
  • Resistance Level
  • BCAB $2.53
  • QIPT $2.77
  • Average True Range (ATR)
  • BCAB 0.26
  • QIPT 0.10
  • MACD
  • BCAB -0.07
  • QIPT -0.03
  • Stochastic Oscillator
  • BCAB 20.08
  • QIPT 14.89

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Share on Social Networks: